Publications

Found 4 results
Filters: Author is B.G. Ye  [Clear All Filters]
2016
H. X. Liu, Li, J., Ye, B. G., Liu, H. X., Li, J., and Ye, B. G., Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.ACKNOWLEDGMENTSResearch supported by Planning of Science and Technology in Guangdong Province (#2016A020215162) and Planning of Science and Technology in Guangzhou City (#2104YZ-00062). REFERENCESAbbas M, Srivastava K, Imran M, Banerjee M, et al (2014). Association of CYP1A1 gene variants rs4646903 (T>C) and rs1048943 (A>G) with cervical cancer in a North Indian population. Eur. J. Obstet. Gynecol. Reprod. Biol. 176: 68-74. http://dx.doi.org/10.1016/j.ejogrb.2014.02.036 Abdull Razis AF, Konsue N, Ioannides C, et al (2015). Inhibitory effect of phenethyl isothiocyanate against benzo[a] pyrene-induced rise in CYP1A1 mRNA and apoprotein levels as its chemopreventive properties. Asian Pac. J. Cancer Prev. 16: 2679-2683. http://dx.doi.org/10.7314/APJCP.2015.16.7.2679 BroshRMJret al. (2013). DNA helicases involved in DNA repair and their roles in cancer. Nat. Rev. Cancer 13: 542-558. http://dx.doi.org/10.1038/nrc3560 Chen B, Zhou Y, Yang P, Wu XT, et al (2012). Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Mol. Biol. Rep. 39: 1305-1313. http://dx.doi.org/10.1007/s11033-011-0863-6 Choi JR, Park SY, Noh OK, Koh YW, et al (2016). Gene mutation discovery research of non-smoking lung cancer patients due to indoor radon exposure. Ann. Occup. Environ. Med. 28: 13. http://dx.doi.org/10.1186/s40557-016-0095-2 García-González MA, Quintero E, Bujanda L, Nicolás D, et al (2012). Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis 27: 771-777. http://dx.doi.org/10.1093/mutage/ges049 Ghoshal U, Tripathi S, Kumar S, Mittal B, et al (2014). Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection. Gastric Cancer 17: 226-234. http://dx.doi.org/10.1007/s10120-013-0269-3 Hecht SS, Carmella SG, Chen M, Dor Koch JF, et al (1999). Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 59: 590-596. Hecht SS, Carmella SG, Murphy SE, Stepanov I, et al (2016). Tobacco smoke toxicant and carcinogen biomarkers and lung cancer susceptibility in smokers. J. Thorac. Oncol. 11: S7-S8. http://dx.doi.org/10.1016/j.jtho.2015.12.011 Hezova R, Bienertova-Vasku J, Sachlova M, Brezkova V, et al (2012). Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population. Eur. J. Med. Res. 17: 17. http://dx.doi.org/10.1186/2047-783X-17-17 Huang G, Cai S, Wang W, Zhang Q, et al (2013). Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies. PLoS One 8: e68457. http://dx.doi.org/10.1371/journal.pone.0068457 Ibarrola-Villava M, Martin-Gonzalez M, Lazaro P, Pizarro A, et al (2012). Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism. Br. J. Dermatol. 166: 1176-1183. http://dx.doi.org/10.1111/j.1365-2133.2012.10831.x Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y, et al (2012). Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J. Thorac. Oncol. 7: 954-962. http://dx.doi.org/10.1097/JTO.0b013e31824de30f Li D, Dandara C, Parker MI, et al (2010). The 341C/T polymorphism in the GSTP1 gene is associated with increased risk of oesophageal cancer. BMC Genet. 11: 47. http://dx.doi.org/10.1186/1471-2156-11-47 Li W, Li K, Zhao L, Zou H, et al (2014). DNA repair pathway genes and lung cancer susceptibility: a meta-analysis. Gene 538: 361-365. http://dx.doi.org/10.1016/j.gene.2013.12.028 Liu XL, Liu LD, Zhang SG, Dai SD, et al (2015). Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer. Genet. Mol. Res. 14: 13496-13503. http://dx.doi.org/10.4238/2015.October.28.10 Malvezzi M, Bosetti C, Rosso T, Bertuccio P, et al (2013). Lung cancer mortality in European men: trends and predictions. Lung Cancer 80: 138-145. http://dx.doi.org/10.1016/j.lungcan.2013.01.020 Malvezzi M, Bertuccio P, Rosso T, Rota M, et al (2015). European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann. Oncol. 26: 779-786. http://dx.doi.org/10.1093/annonc/mdv001 Mota P, Silva HC, Soares MJ, Pego A, et al (2015). Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility. J. Cancer Res. Clin. Oncol. 141: 851-860. http://dx.doi.org/10.1007/s00432-014-1868-z Qian B, Zhang H, Zhang L, Zhou X, et al (2011). Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer 73: 138-146. http://dx.doi.org/10.1016/j.lungcan.2010.11.018 Wang M, Chu H, Zhang Z, Wei Q, et al (2013). Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer. J. Biomed. Res. 27: 179-192. http://dx.doi.org/10.7555/JBR.27.20130034 Xu CH, Wang Q, Qian Q, Zhan P, et al (2013). CYP1A1 exon7 polymorphism is associated with lung cancer risk among the female population and among smokers: a meta-analysis. Tumour Biol. 34: 3901-3911. http://dx.doi.org/10.1007/s13277-013-0978-6 Zhao Y, Wang B, Hu K, Wang J, et al (2015). Glutathione S-transferase θ1 polymorphism contributes to lung cancer susceptibility: A meta-analysis of 26 case-control studies. Oncol. Lett. 9: 1947-1953.  
H. X. Liu, Li, J., Ye, B. G., Liu, H. X., Li, J., and Ye, B. G., Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.ACKNOWLEDGMENTSResearch supported by Planning of Science and Technology in Guangdong Province (#2016A020215162) and Planning of Science and Technology in Guangzhou City (#2104YZ-00062). REFERENCESAbbas M, Srivastava K, Imran M, Banerjee M, et al (2014). Association of CYP1A1 gene variants rs4646903 (T>C) and rs1048943 (A>G) with cervical cancer in a North Indian population. Eur. J. Obstet. Gynecol. Reprod. Biol. 176: 68-74. http://dx.doi.org/10.1016/j.ejogrb.2014.02.036 Abdull Razis AF, Konsue N, Ioannides C, et al (2015). Inhibitory effect of phenethyl isothiocyanate against benzo[a] pyrene-induced rise in CYP1A1 mRNA and apoprotein levels as its chemopreventive properties. Asian Pac. J. Cancer Prev. 16: 2679-2683. http://dx.doi.org/10.7314/APJCP.2015.16.7.2679 BroshRMJret al. (2013). DNA helicases involved in DNA repair and their roles in cancer. Nat. Rev. Cancer 13: 542-558. http://dx.doi.org/10.1038/nrc3560 Chen B, Zhou Y, Yang P, Wu XT, et al (2012). Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Mol. Biol. Rep. 39: 1305-1313. http://dx.doi.org/10.1007/s11033-011-0863-6 Choi JR, Park SY, Noh OK, Koh YW, et al (2016). Gene mutation discovery research of non-smoking lung cancer patients due to indoor radon exposure. Ann. Occup. Environ. Med. 28: 13. http://dx.doi.org/10.1186/s40557-016-0095-2 García-González MA, Quintero E, Bujanda L, Nicolás D, et al (2012). Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis 27: 771-777. http://dx.doi.org/10.1093/mutage/ges049 Ghoshal U, Tripathi S, Kumar S, Mittal B, et al (2014). Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection. Gastric Cancer 17: 226-234. http://dx.doi.org/10.1007/s10120-013-0269-3 Hecht SS, Carmella SG, Chen M, Dor Koch JF, et al (1999). Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 59: 590-596. Hecht SS, Carmella SG, Murphy SE, Stepanov I, et al (2016). Tobacco smoke toxicant and carcinogen biomarkers and lung cancer susceptibility in smokers. J. Thorac. Oncol. 11: S7-S8. http://dx.doi.org/10.1016/j.jtho.2015.12.011 Hezova R, Bienertova-Vasku J, Sachlova M, Brezkova V, et al (2012). Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population. Eur. J. Med. Res. 17: 17. http://dx.doi.org/10.1186/2047-783X-17-17 Huang G, Cai S, Wang W, Zhang Q, et al (2013). Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies. PLoS One 8: e68457. http://dx.doi.org/10.1371/journal.pone.0068457 Ibarrola-Villava M, Martin-Gonzalez M, Lazaro P, Pizarro A, et al (2012). Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism. Br. J. Dermatol. 166: 1176-1183. http://dx.doi.org/10.1111/j.1365-2133.2012.10831.x Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y, et al (2012). Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J. Thorac. Oncol. 7: 954-962. http://dx.doi.org/10.1097/JTO.0b013e31824de30f Li D, Dandara C, Parker MI, et al (2010). The 341C/T polymorphism in the GSTP1 gene is associated with increased risk of oesophageal cancer. BMC Genet. 11: 47. http://dx.doi.org/10.1186/1471-2156-11-47 Li W, Li K, Zhao L, Zou H, et al (2014). DNA repair pathway genes and lung cancer susceptibility: a meta-analysis. Gene 538: 361-365. http://dx.doi.org/10.1016/j.gene.2013.12.028 Liu XL, Liu LD, Zhang SG, Dai SD, et al (2015). Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer. Genet. Mol. Res. 14: 13496-13503. http://dx.doi.org/10.4238/2015.October.28.10 Malvezzi M, Bosetti C, Rosso T, Bertuccio P, et al (2013). Lung cancer mortality in European men: trends and predictions. Lung Cancer 80: 138-145. http://dx.doi.org/10.1016/j.lungcan.2013.01.020 Malvezzi M, Bertuccio P, Rosso T, Rota M, et al (2015). European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann. Oncol. 26: 779-786. http://dx.doi.org/10.1093/annonc/mdv001 Mota P, Silva HC, Soares MJ, Pego A, et al (2015). Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility. J. Cancer Res. Clin. Oncol. 141: 851-860. http://dx.doi.org/10.1007/s00432-014-1868-z Qian B, Zhang H, Zhang L, Zhou X, et al (2011). Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer 73: 138-146. http://dx.doi.org/10.1016/j.lungcan.2010.11.018 Wang M, Chu H, Zhang Z, Wei Q, et al (2013). Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer. J. Biomed. Res. 27: 179-192. http://dx.doi.org/10.7555/JBR.27.20130034 Xu CH, Wang Q, Qian Q, Zhan P, et al (2013). CYP1A1 exon7 polymorphism is associated with lung cancer risk among the female population and among smokers: a meta-analysis. Tumour Biol. 34: 3901-3911. http://dx.doi.org/10.1007/s13277-013-0978-6 Zhao Y, Wang B, Hu K, Wang J, et al (2015). Glutathione S-transferase θ1 polymorphism contributes to lung cancer susceptibility: A meta-analysis of 26 case-control studies. Oncol. Lett. 9: 1947-1953.